Quint Media Inc Stock Other OTC
Equities
US74874T1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-07 | IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc. | CI |
05-06 | Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction. | CI |
Sales 2022 | 0.57 0.78 | Sales 2023 | 0.61 0.83 | Capitalization | 5.54M 7.61M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.5M | Net income 2023 | -30M -41.26M | EV / Sales 2022 | 44,915,754 x |
Net Debt 2022 | 3.98M 5.47M | Net Debt 2023 | 18.76M 25.8M | EV / Sales 2023 | 40,045,900 x |
P/E ratio 2022 |
-1.59
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.39% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 43 | 08-12-31 | |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Trevor McCartney
IRO | Public Communications Contact | - | 19-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 20-06-17 |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Director of Finance/CFO | 43 | 08-12-31 |
1st Jan change | Capi. | |
---|---|---|
+18.73% | 125B | |
+15.48% | 108B | |
-6.05% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-13.36% | 16.34B | |
+0.97% | 13.56B | |
+25.09% | 11.59B |